Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,484 | 0 | 0 | N/A | 0 |
| TOTAL | $77,653 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 40 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 2,013 | 0 | 0 | 0 | 0 |
| TOTAL | $2,053 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $79,706 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 95,229 | 0 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 439 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 4,452 | 0 | 0 | N/A | 0 |
| Other current liabilities | 107,373 | 0 | 0 | N/A | 0 |
| TOTAL | $207,493 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,611 | 0 | 0 | N/A | 0 |
| Other Non-Current Liabilities | 2,063 | 0 | 0 | 0 | 0 |
| TOTAL | $24,674 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $232,167 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,527 | N/A | N/A | N/A | N/A |
| Retained earnings | -158,413 | 0 | 0 | N/A | 0 |
| TOTAL | $-152,461 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $79,706 | $0 | $0 | $0 | $0 |